Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
Authors:
- Lars RydénLRLars Rydén
- Suad EfendicSESuad Efendic
- Johan HerlitzJHJohan Herlitz
- Peter NicolPNPeter Nicol
- Anders WaldenstromAnders Waldenstrom
- Hans WedelHWHans Wedel
- Lennart WelinLWLennart Welin
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The diabetic heart: metabolic causes for the development of a cardiomyopathyCardiovascular Research, 1992
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Cardiomyopathy of OverloadNew England Journal of Medicine, 1990
- RELATION BETWEEN PLASMA FREE FATTY ACIDS AND ARRHYTHMIAS WITHIN THE FIRST TWELVE HOURS OF ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1983
- Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarctionAmerican Heart Journal, 1981
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: Relationship to infarct extent and mortalityAmerican Heart Journal, 1981
- Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patientsAmerican Heart Journal, 1980
- Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.BMJ, 1977
- Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarctionThe American Journal of Cardiology, 1962